Company page

Vaccinex, Inc.

Vaccinex, Inc. (Ticker: VCNX) is a public company operating in the American market with a market capitalization of approximately $2.68 million. The company focuses on developing innovative therapies for cancer and neurodegenerative diseases. Vaccinex aims to advance its research and product pipeline to address significant medical needs.